OS Therapies Analyst Price Targets - Benzinga

OS Therapies Inc

OSTXAMEX

Trade with Public

Trade with Public

$1.62

0.074.52%

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Informe de acciones

OS Therapies Analyst Price Targets - Benzinga

OS Therapies Analyst Price Targets

Wall Street analyst price targets and consensus rating for OS Therapies (OSTX).

Price Target Range — 9 Quarters

Analyst Consensus — 5 Analysts

5Buy

Consensus RatingBuy# Analysts5Avg. Consensus PT$15

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 9, 2026	Roth Capital	Adam Walsh	Initiate	Buy	$7
May 19, 2026	Lake Street	Chad Messer	PT Cut	Buy	$14→$13
Apr 30, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$20
Apr 8, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$20
Mar 27, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$20
Mar 9, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$20
Feb 5, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$20
Jan 5, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$20
Dec 15, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$20
Dec 9, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$20
Dec 5, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$20
Nov 21, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$20
Nov 18, 2025	Lake Street	Chad Messer	PT Cut	Buy	$18→$17
Nov 17, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$20
Oct 10, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$20
Sep 30, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$20
Sep 12, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$20
Sep 2, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$20
Aug 27, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$20
Aug 20, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$20

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Roth Capital Initiates Coverage On OS Therapies with Buy Rating, Announces Price Target of $7

Roth Capital analyst Adam Walsh initiates coverage on OS Therapies (AMEX:OSTX) with a Buy rating and announces Price Target of $7.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on OS Therapies, Lowers Price Target to $13

Lake Street analyst Chad Messer maintains OS Therapies (AMEX:OSTX) with a Buy and lowers the price target from $14 to $13.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on OS Therapies, Maintains $20 Price Target

D. Boral Capital analyst Jason Kolbert maintains OS Therapies (AMEX:OSTX) with a Buy and maintains $20 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on OS Therapies, Maintains $20 Price Target

D. Boral Capital analyst Jason Kolbert maintains OS Therapies (AMEX:OSTX) with a Buy and maintains $20 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on OS Therapies, Maintains $20 Price Target

D. Boral Capital analyst Jason Kolbert maintains OS Therapies (AMEX:OSTX) with a Buy and maintains $20 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on OS Therapies, Maintains $20 Price Target

D. Boral Capital analyst Jason Kolbert maintains OS Therapies (AMEX:OSTX) with a Buy and maintains $20 price target.

Benzinga Newsdesk